Background Cancer, a major global health challenge, not only threatens lives but also imposes severe financial burdens, known ...

A temporary freeze on meetings on the National Institutes of Health could lead to delays in disbursing research grants and in ...

However, the treatment that works best for you will depend on many factors, such as the biology ... type of cancer you have, and how far your cancer has spread. A 2024 systematic review found ...

From 1,085 citations identified, 48 studies with 15,368 men with mCRPC met inclusion criteria. Most studies were retrospective cohorts (n = 39) from Europe (n = 22) and North America (n = 18), with ...

There’s widespread confusion and fear among scientists and doctors on the sprawling National Institutes of Health campus and at institutions dependent on the agency’s funding.

Amgen, Inc. ( NASDAQ: AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call February 12, 2025 11:20 AM ET Narimon Honarpour - Senior Vice President, Global Development Justin Claeys - ...

Cancer immunotherapy is a therapy used to treat ... insights into potential determinants of CAR-T cell response. This Review discusses how microfluidic and other fluidic devices can be leveraged ...

Therefore, elucidation of the new functions of p53 and autophagy could contribute to the development of novel therapeutic approaches in cancer biology. However ... of autophagy pathway in cancer cells ...

Oncogenes are typically overexpressed in tumor tissues and often linked to poor prognosis. However, recent advancements in bioinformatics have revealed that many highly expressed genes in tumors are ...

Stanford Medicine researchers sifted through thousands of single nucleotide mutations in DNA to identify fewer than 400 that are functionally associated with inherited cancer risk.

Pancreatic cancer (PC) is the worst prognosis cancer globally, with just 13% of patients who are diagnosed with PC surviving for 5 years or more after initial diagnosis. Early detection of PC is the ...

Two new studies represent a big step toward developing innovative molecular therapies capable of disrupting the ...